The Influence of Socioeconomic Status on Esophageal Cancer in Taiwan: A Population-Based Study.
esophageal adenocarcinoma
esophageal cancer
esophageal squamous cell carcinoma
socioeconomic status
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
07 Apr 2022
07 Apr 2022
Historique:
received:
30
12
2021
revised:
18
03
2022
accepted:
06
04
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
Esophageal cancer has extreme worldwide demographic and histologic variations in occurrence; thus, understanding the pathogenesis of esophageal cancer must be region- or country-based. We examined the incidence and tumor stage at diagnosis of esophageal cancer in relation to patients' socioeconomic status (SES) in Taiwan. This retrospective cohort study used data from Taiwan's National Health Insurance Research Database and Taiwan Cancer Registry collected between January 2008 and December 2014. The records of 40- to 79-year-old patients diagnosed with esophageal cancer were retrieved. The distribution of the crude incidence rates of esophageal cancer by occupation and income variables was studied retrospectively. Cox proportional hazard model was used to adjust for potential confounders and compare the esophageal cancer incidence among four independent variables: age, gender, occupation, and income. Logistic regression analysis was applied to find the power of the independent variables on the odds ratio of late-stage presentation. The analysis included 7763 subjects. Esophageal squamous cell carcinoma (ESCC) was the predominant histological type (96.6%) and 94.4% of patients were male. The peak affected age for ESCC was 50 to 59 years, whereas the risk of esophageal adenocarcinoma increased progressively with age. The risk of ESCC was significantly unfavorable for the most disadvantaged group, either in occupation or income, while in EAC, risk was unrelated to either factor. The stage of cancer at diagnosis was lower in the highest income groups than in the other two groups. Significant SES disparities in esophageal cancer incidence, based on occupation and income, are present in Taiwan. Low SES populations have a higher percentage of late-stage diagnosis. Resolution of the increasing socioeconomic disparities and narrowing the gaps in health inequities in Taiwan are needed.
Sections du résumé
BACKGROUND
BACKGROUND
Esophageal cancer has extreme worldwide demographic and histologic variations in occurrence; thus, understanding the pathogenesis of esophageal cancer must be region- or country-based. We examined the incidence and tumor stage at diagnosis of esophageal cancer in relation to patients' socioeconomic status (SES) in Taiwan.
METHOD
METHODS
This retrospective cohort study used data from Taiwan's National Health Insurance Research Database and Taiwan Cancer Registry collected between January 2008 and December 2014. The records of 40- to 79-year-old patients diagnosed with esophageal cancer were retrieved. The distribution of the crude incidence rates of esophageal cancer by occupation and income variables was studied retrospectively. Cox proportional hazard model was used to adjust for potential confounders and compare the esophageal cancer incidence among four independent variables: age, gender, occupation, and income. Logistic regression analysis was applied to find the power of the independent variables on the odds ratio of late-stage presentation.
RESULTS
RESULTS
The analysis included 7763 subjects. Esophageal squamous cell carcinoma (ESCC) was the predominant histological type (96.6%) and 94.4% of patients were male. The peak affected age for ESCC was 50 to 59 years, whereas the risk of esophageal adenocarcinoma increased progressively with age. The risk of ESCC was significantly unfavorable for the most disadvantaged group, either in occupation or income, while in EAC, risk was unrelated to either factor. The stage of cancer at diagnosis was lower in the highest income groups than in the other two groups.
CONCLUSION
CONCLUSIONS
Significant SES disparities in esophageal cancer incidence, based on occupation and income, are present in Taiwan. Low SES populations have a higher percentage of late-stage diagnosis. Resolution of the increasing socioeconomic disparities and narrowing the gaps in health inequities in Taiwan are needed.
Identifiants
pubmed: 35455711
pii: jpm12040595
doi: 10.3390/jpm12040595
pmc: PMC9027796
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Taichung Veterans General Hospital
ID : TCVGH-NHRI10901,TCVGH-1097306C, TCVGH-1097328D, TCVGH-109G221, and TCVGH-YM1090103
Références
J BUON. 2017 Jul-Aug;22(4):1088-1091
pubmed: 28952239
Ann Oncol. 2014 Jan;25(1):283-90
pubmed: 24356640
Esophagus. 2019 Jan;16(1):1-24
pubmed: 30171413
Sci Rep. 2018 Mar 14;8(1):4522
pubmed: 29540708
Int J Cancer. 2003 Jul 10;105(5):692-700
pubmed: 12740920
Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1060-1066
pubmed: 28815803
Int J Cancer. 2005 Jan 20;113(3):475-82
pubmed: 15455377
Medicine (Baltimore). 2016 Jul;95(27):e4140
pubmed: 27399129
Clin Gastroenterol Hepatol. 2016 Mar;14(3):338-347.e1
pubmed: 26484704
Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1468-70
pubmed: 20501776
Semin Oncol. 2004 Aug;31(4):450-64
pubmed: 15297938
N Engl J Med. 2008 Jun 5;358(23):2468-81
pubmed: 18525043
Cancer Biol Med. 2017 Feb;14(1):33-41
pubmed: 28443201
Gastroenterology. 2018 Jan;154(2):360-373
pubmed: 28823862
Milbank Q. 2005;83(4):731-57
pubmed: 16279965
Jpn J Clin Oncol. 2015 Mar;45(3):291-6
pubmed: 25601947
Nat Clin Pract Gastroenterol Hepatol. 2008 Sep;5(9):517-26
pubmed: 18679388
Gut. 2015 Mar;64(3):381-7
pubmed: 25320104
JAMA. 2005 Dec 14;294(22):2879-88
pubmed: 16352796
Soc Sci Med. 2012 Aug;75(4):761-9
pubmed: 22475407
Lancet. 2013 Feb 2;381(9864):400-12
pubmed: 23374478
N Engl J Med. 2003 Dec 4;349(23):2241-52
pubmed: 14657432
Cancer. 1998 Nov 15;83(10):2049-53
pubmed: 9827707
Ann Surg Oncol. 2013 Sep;20(9):3023-30
pubmed: 23525703
Lancet. 2008 Nov 8;372(9650):1661-9
pubmed: 18994664
London J Prim Care (Abingdon). 2010 Dec;3(2):115-9
pubmed: 25949636
J Clin Gastroenterol. 2012 Nov-Dec;46(10):833-9
pubmed: 22460163
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
J Transl Med. 2015 Jul 24;13:241
pubmed: 26205792
JAMA. 2013 Aug 14;310(6):627-36
pubmed: 23942681
Cancer Causes Control. 2010 Feb;21(2):269-74
pubmed: 19866363
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Glob Health Action. 2014 May 15;7:23574
pubmed: 24848657
Cancer Causes Control. 2003 Mar;14(2):167-74
pubmed: 12749722
Int J Equity Health. 2018 Jun 15;17(1):79
pubmed: 29903010
Int J Epidemiol. 2009 Aug;38(4):978-88
pubmed: 19416955
PLoS One. 2017 Oct 11;12(10):e0186350
pubmed: 29020052
Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1754-61
pubmed: 16030113
Chin J Cancer. 2012 Jun;31(6):281-6
pubmed: 22507220